Categories: Inova in the NewsITMI

Personalized medicine could mean big business for D.C.-area companies, The Washington Post, May 31, 2015

The American health-care industry’s pivot to personalized medicine has attracted the interest of an unlikely group of companies — government contractors.

As health-care providers explore this new model of treatment, which involves the study of the human genome to provide personalized care, they face a problem with which many in government are familiar: analyzing an overwhelming amount of data. Read more.

InovaNewsroom

Share
Published by
InovaNewsroom
Tags: ICPH

Recent Posts

Giving the gift of life: Demystifying the process of becoming a living kidney donor

Heather Perez Saiz, MA, LCSW, CCTSW, is the Independent Living Donor Advocate at Inova Fairfax…

2 days ago

Inova Schar Heart and Vascular receives $1.4 million pediatric heart transplant research grant

Palak Shah, MD, MS Fairfax, VA — A research team at Inova Schar Heart and…

3 days ago

7 ways to lower blood pressure naturally

Jason Bonomo, MD, PhD, is a cardiologist at Inova Schar Heart and Vascular. Dr. Bonomo…

5 days ago

Inova plays a key role in trial of innovative treatment for tricuspid valve regurgitation that is now approved by the FDA

Update as of April 24, 2024: Inova’s structural heart team has now completed the first…

2 weeks ago

Inova receives $20 million gift from the Peterson Family to support critical needs

The Peterson Family Fairfax, VA, April 16, 2024 –  Inova today announced a transformational gift…

2 weeks ago

Mindful, intuitive eating for health: ditching the diet and feeding the soul

Lauren Trahan, MS, RD is a Registered Dietitian. She serves patients in Inova Cardiac and…

3 weeks ago